New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 19, 2014
08:49 EDTTGT, FB, AAPL, TWTR, BBRY, IDCC, BX, AIG, NFLX, QCOM, NVS, GIS, SSNLF, T, BAC, ACTOn the Fly: Periodicals Wrap
WSJ: AT&T (T) discloses national security requests for thousands of accounts...China acknowledges anti-monopoly probe of Qualcomm (QCOM), InterDigital (IDCC)...Samsung (SSNLF) sees mix of hardware, software for distribution platform...Netflix (NFLX) faces video slowdown as broadband fee issues debated...Actavis (ACT) expected to seek more deals...REUTERS: General Mills (GIS) seeks deals in fast growing emerging markets...AIG (AIG) accused of holding BofA (BAC) $8.5B settlement 'hostage'...Novartis (NVS) Tokyo unit raided by prosecutors...BLOOMBERG: Blackstone (BX) acquires minority stake in Senator Investment Group...BlackBerry (BBRY) CEO blasts T-Mobile for pushing change to iPhones (AAPL)...OTHER NEWS: Banks' cost for Target (TGT) data breach over $200M, AP reports...Twitter (TWTR) could look to follow Facebook (FB) as app distribution platform, Re/code reports.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 >>
September 28, 2015
09:06 EDTSSNLFGlobal Payments announces full support for Samsung Pay in the U.S.
Global Payments Inc. (GPN) is pleased to offer its merchants in the United States the ability to accept Samsung Pay (SSNLF). As a Samsung Pay-qualified payment provider, Global Payments' suite of payment solutions is fully enabled for acceptance, allowing merchants to offer their customers the convenience of Samsung Pay.
08:52 EDTAAPLOn The Fly: Pre-market Movers
IN FOCUS: Apple (AAPL) after announcing it set a record by selling more than 13M new iPhone 6s and iPhone 6s Plus models in the first three days after launch of the devices. HIGHER: Media General (MEG), up 22% after Nexstar (NXST) announced a proposal to acquire the company for cash Nexstar shares currently valued at $14.50 per Media General share... Alcoa (AA), up 5.4% after announcing that its board has unanimously approved a plan to separate into two independent, publicly-traded companies - an Upstream company that will operate under the Alcoa name and a new Value-Add company whose name will be announced at a later date... Atmel (ATML), up 7% after Reuters reported that Cypress Semiconductor (CY) is working on a competing bid to Dialog Semiconductor's (DLGNF) takeover offer... J.C. Penney (JCP), up 3% after Sterne Agee CRT upgraded the stock to Buy from Neutral after meeting with the company's new CEO. DOWN AFTER EARNINGS: Cal-Maine Foods (CALM), down 8%. ALSO LOWER: Verastem (VSTM), down 50% after stopping enrollment in the Phase 2 study of VS-6063 for patients with mesothelioma for futility after a Data Safety Monitoring Board review of a pre-planned interim analysis... Fiat Chrysler (FCAU), down 3.7% after the Detroit Free Press said some local UAW workers rejected a four-year tentative pact between the United Auto Workers and the company... Williams (WMB), down 3% after Energy Transfer Equity (ETE) announced a business combination transaction valued at approximately $37.7B, including the assumption of debt and other liabilities. Under the deal, an affiliate of ETE, will acquire Williams at an implied current price of $43.50 per Williams share.
08:46 EDTAAPLUS District Court denies Apple's motion to appeal Kessler ruling
Network-1 Technologies (NTIP) announced that the United States District Judge Robert Schroeder III of the Eastern District of Texas issued an Order denying a motion made by Apple (AAPL) to certify for appeal the Court's prior ruling denying Apple's motion for summary judgment based on the Kessler Doctrine in a patent infringement suit filed by Mirror Worlds Technologies, Inc., a wholly owned subsidiary of Network-1, against Apple. In December 2014, Apple brought a motion for summary judgment arguing that Mirror Worlds was precluded under the Kessler Doctrine from initiating patent litigation against Apple because of an earlier case brought by the previous owner of the Mirror Worlds patent portfolio against Apple. In July, Judge Schroeder denied Apple's motion and granted Mirror Worlds' cross-motion that the Kessler Doctrine does not apply. Apple filed a motion seeking to allow it to file an interlocutory appeal (prior to a judgment) of Judge's Schroeder's Order to the Federal Circuit Court of Appeals.
08:30 EDTAAPLApple says has sold over 13M new iPhone 6s, 6s Plus models
Apple announced it has sold more than 13 million new iPhone 6s and iPhone 6s Plus models, a new record, just three days after launch. iPhone 6s and iPhone 6s Plus will be available in more than 40 additional countries beginning October 9 including Italy, Mexico, Russia, Spain and Taiwan. The new iPhones will be available in over 130 countries by the end of the year. "Sales for iPhone 6s and iPhone 6s Plus have been phenomenal, blowing past any previous first weekend sales results in Apple's history," said Tim Cook, Apple's CEO. "Customers' feedback is incredible and they are loving 3D Touch and Live Photos, and we can't wait to bring iPhone 6s and iPhone 6s Plus to customers in even more countries on October 9."
08:30 EDTAAPLApple says has sold over 13M new iPhone 6s, 6s Plus models
Subscribe for More Information
07:58 EDTNVSNovartis to hold a conference call
Subscribe for More Information
07:56 EDTNFLXNetflix appears to have a hit with Narcos, says UBS
UBS analyst Doug Mitchelson said the firm's "Evidence Lab" found that Netflix' Narcos is already among the top four most liked of the company's original shows on Facebook in less than 1 month after premiering, adding that the reception of the show has been particularly strong in Latin America. The apparent hit increases the firm's confidence in Q3 subscriber growth estimates for both the U.S. and international markets, Mitchelson told investors in a research note. The analyst also noted that Netflix ranked sixth in week 1 and 24th in week 2 in terms of iOS app downloads for Japan after launching there. Though the launch is the weakest internationally since 2013, the size of the market should still let it contribute to Q3, wrote Mitchelson who keeps a Buy rating and $143 price target on Netflix shares.
07:38 EDTAAPLBox to hold a user conference
Subscribe for More Information
07:31 EDTBBRYBlackBerry price target lowered to $7.50 from $10 at UBS
UBS analyst Amitabh Passi said he agrees with BlackBerry CEO John Chen that the company's success hinges on its ability to build a comprehensive software portfolio, but the question is whether the hardware business can stabilize before the software business gains traction in an intense competitive environment. Passi lowered his price target on BlackBerry shares to $7.50 from $10 and keeps a Neutral rating on the stock.
07:28 EDTT, SSNLFSamsung to pay customers up to $120 for buying new Galaxy phone, Verge says
Samsung's (SSNLF) new promotion in the U.S. will pay the rest of a customer's monthly payments in 2015 towards a new Galaxy S6, S6 Edge, S6 Edge+, or Galaxy Note 5, the Verge reports. The promotion will result in $120 off the price of any of those phones if users buy one under a new carrier installment plan between now and October 9, the report says. AT&T (T) will sit the promotion out, the report says. Reference Link
07:24 EDTAAPLiPhone 7 may have waterproof, dustproof design, AppleInsider says
Apple's iPhone 7 is well into the prototyping phase, with current test models featuring a waterproof and dustproof design with a non-metal chassis, AppleInsider reports, citing a post from Weibo. Reference Link
07:21 EDTAAPLKnowles upgraded on increased Apple content at FBR Capital
FBR Capital analyst Christopher Rolland upgraded Knowles (KN) to Market Perform from Underperform saying Chipworks identified a fourth mic made by the company in Apple's (AAPL) iPhone 6S, up from three in the previous version of the smartphone. Further, key Knowles competitor has encountered difficulties sourcing qualified MEMS wafers from its third-party manufacturing partner, Rolland tells investors in a research note. He raised his price target for shares to $18 from $17.
06:42 EDTTGTPerfume makers look to Wal-Mart, Target, WSJ reports
Subscribe for More Information
06:27 EDTNFLXNetflix acquires rights to three more TV shows, Variety reports
Netflix has acquired the global streaming rights to CW's "Jane the Virgin," USA's "Colony" and CBS's "Zoo," sources confirm to Variety. Netflix previously announced the acquisition of exclusive global rights to ABC's "How to Get Away with Murder." Reference Link
06:06 EDTFBFacebook 'dramaticlaly' increases virtual reality spending, Financial Times says
Facebook has increased its virtual reality investment since the Oculus acquisitoin and is expected to spend even more over the next decade, reports the Financial Times. Facebook CTO Mike Schroepfer said in an interview, "We are investing more year over year... We've got a multiyear plan for this worked out over a fairly long horizon. Although Schroepfer declined to give specific numbers, Facebook is expected to invest billions of dollars over the next several years. Reference Link
06:05 EDTAAPLiPhone survey shows trend to higher capacity continues, says Piper Jaffray
Subscribe for More Information
September 27, 2015
18:48 EDTNVSNovartis reports updated Phase 3 data on Tafinlar-Mekinist for melanoma
Subscribe for More Information
16:24 EDTQCOMQualcomm commits to invest $150M in Indian startups
Subscribe for More Information
16:16 EDTNVSNovartis reports Phase 3 reults on Afinitor for neuroendocrine tumors
Novartis announced results of a Phase 3 pivotal study showing Afinitor, or everolimus, tablets reduced the risk of progression by 52% versus placebo in patients with advanced, progressive, nonfunctional neuroendocrine tumors of gastrointestinal or lung origin. Additionally, the data show everolimus, a mammalian target of rapamycin inhibitor, extended median progression free survival by 7.1 months. Median PFS by central review was 11 months in the everolimus arm and 3.9 months in the placebo arm. Overall survival was a key secondary endpoint of the trial. While the OS data are not mature, the first interim analysis showed a trend favoring the everolimus arm, according to Novartis. Additional analyses are planned. Another secondary endpoint was best overall response rate. The study found that 64% of patients receiving everolimus experienced at least some degree of tumor shrinkage compared to 26% of those on placebo. Adverse events were consistent with the known safety profile of everolimus. The results of the RADIANT-4 study will serve as the basis of worldwide regulatory submissions for Afinitor for the treatment of advanced, progressive, nonfunctional GI and lung NET, Novartis said.
13:50 EDTBACBank of America likely to increase dividend, buyback plans, Barron's says
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use